Kamada Ltd. (KMDA) Social Stream
Kamada Ltd (KMDA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KMDA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 16, 2022
The Trend in the Analyst Price Target
KMDA's average price target has moved down $0 over the prior 13 months.
KMDA reports an average of 89.51% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
KMDA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
KMDA's average broker recommendation rating improved by 0.5 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KMDA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Kamada Ltd's number of analysts covering the stock is greater than 4.69% of them.
- Kamada Ltd's variance in analysts' estimates is lower than 83.52% of Pharmaceutical Products stocks.
- In terms of how Kamada Ltd fares relative to Healthcare stocks, note that its average analyst price target is higher than 51.12% of that group.
- Kamada Ltd's upside potential (average analyst target price relative to current price) is greater than 95.02% of Pharmaceutical Products stocks.
What is the outlook for KMDA? Use POWR Ratings for clearer insight into price direction.